Acute Promyelocytic Leukemia - AML with t(15;17)(q22;q12)From $1Table of contentsPlease contribute to the site. See the contributor's FAQ for more information. DefinitionAcute promyelocytic leukemia is a subtype of acute myelogenous leukemia (AML), a cancer of the blood and bone marrow. It is also known as acute progranulocytic leukemia; APL; AML with t(15;17)(q22;q12), PML-RARA and variants; FAB subtype M3 and M3 variant. In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARα or RARA) gene and is unique from other forms of AML in its responsiveness to all trans retinoic acid (ATRA) therapy. Sample CasesClick here for instructions on how to download the free FCS Express Reader to view and manipulate the sample cases.
EpidemiologyAcute promyelocytic leukemia (APL) represents 5-8% of AML in adults. The median age is approximately 40 years, which is considerably younger than the other subtypes of AML (70 years). The incidence is increased in patients originated in Latin American countries Possible causesSimilar to ALL, possible factors that have been associated with AML (and MDS) are viruses, radiation, cytotoxic chemotherapy and benzene exposure. Exposure to the atomic bomb of WWII increased the incidence of all leukemias including AML. In addition, smoking is attributed to an increased risk. MorphologyThere are two subtypes of APL based on morphologic features; hypergranular and microgranular (hypogranular).
ImmunophenotypingBlasts in APL can be initially identified using a SSC vs CD45 plot. As noted by the differences in morphology, different subtypes of APL exhibit different CD45 vs SSC plots. Correlation to morphology is important as hyperganular APL blasts generally fall in the same region as normal granulocytes. Hypogranular APL blasts have a lower SSC. Note the correlation with morphology.
Once the blasts are identified and gated, the following markers are useful in classification of APL. Please note flow cytometry is not diagnostic for APL, and must be confirmed with retinoic acid receptor-alpha (RARα) :
Example APL histograms:
Other relevant testsGenetics: Acute promyelocytic leukemia is characterized by chromosomal translocation involving the retinoic acid receptor-alpha gene on chromosome 17 (RARα). In 95% of cases of APL, retinoic acid receptor-alpha (RARα) gene on chromosome 17 is involved in a reciprocal translocation with the promyelocytic leukemia gene (PML) on chromosome 15, a translocation denoted as t(15;17)(q22;q12). Four other gene rearrangements have been described in APL fusing RARα to promyelocytic leukemia zinc finger (PLZF), nucleophosmin (NPM), nuclear matrix associated (NUMA), or signal transducer and activator of transcription 5b (STAT5B) genes. Sub-classificationAPL exists as two types, hypergranular or typical APL and microgranular (hypogranular) APL. APL comprises 5% to 8% of cases of AML and occurs predominately in adults in midlife. Both typical and microgranular APL are commonly associated with disseminated intravascular coagulation (DIC). In microgranular APL, unlike typical APL, the leukocyte count is very high with a rapid doubling time. Flow DiagnosisThe myeloid markers CD33 and CD117 are positive. CD13 and CD34 are generally positive in the hypogranular variant. HLA Dr is characteristically negative (unlike other AMLs) ReferencesContributors to this page
Tags:
Page last modified 21:00, 20 Jun 2008 by Teri
|